Introduction
Glioblastoma is an extremely aggressive neoplasm resistant to intensive therapies including surgical operation, irradiation and anticancer drugs, so that median survival time of the affected patients is estimated to be less than 2 years (Shapiro et al., 1989) . Its histological features are characterized by abundant neovascularization and the paradoxical presence of necrosis, and infiltration of leukocytes (Daumas-Duport et al., 1988) . Predominant blood supply to rapidly growing tumor cells and/or thrombotic occlusion of vessels are believed to contribute to the development of necrosis in glioblastoma. Along with a variety of humoral and microenvironmental factors including growth factors, cytokines, acidosis and hypoxia, involvement of interleukin (IL)-8 in the development and progression of glioblastoma has been intensively investigated, because IL-8 can mediate recruitment of leukocytes and neovascularization by recruiting and activating endothelial cells, and because it can stimulate proliferation and motility of some cancer cells (Koch et al., 1992; Schadendorf et al., 1993; Smith et al., 1994; Luca et al., 1997) .
IL-8, originally identified as a chemotactic factor for leukocytes, belongs to CXC chemotactic cytokine family, and has been demonstrated to play important roles in pathogenesis of autoimmune and inflammatory diseases (Smyth et al., 1991; Koch et al., 1992; Mukaida et al., 1998) . Its expression is therefore tightly controlled in cells. In normal noninflamed cells, its expression is extremely low or undetectable. However, inflammatory cytokines such as tumor necrosis factor (TNF)-a and IL-1 stimulate its expression in various cell types (Mukaida et al., 1990) . In glioblastoma-derived cell lines, IL-8 expression has also been shown to be inducible in response to TNF-a, IL-1, substance P, IL-17, Fas ligand, TNF-related apoptosis-inducing ligand (TRAIL), irradiation and hypoxia (Yamanaka et al., 1993; Desbaillets et al., 1997; Kasahara et al., 1998; Palma and Manzini, 1998; Kehlen et al., 1999; Choi et al., 2001 Choi et al., , 2002 . Furthermore, IL-8 synthesis in vivo was demonstrated in sections prepared from glioblastoma by immunohistochemical analysis (Desbaillets et al., 1997) . However, intracellular signaling pathway leading to IL-8 expression has been poorly elucidated.
A minimal promoter region (À133 to À1) in the human IL-8 gene was identified, which is essential for its transcriptional regulation by inflammatory cytokines (Mukaida et al., 1990) . This region contains potential binding sites for activator protein-1 (AP-1), CCAAT/ enhancer-binding protein b (C/EBPb) and nuclear factor-kB (NF-kB). The NF-kB site is indispensable for the activation of the promoter in all cell types studied, whereas the potential AP-1 and C/EBPb sites are dispensable (Mahe et al., 1991; Yasumoto et al., 1992; Matsusaka et al., 1993) . It is thus suggested that the promoter is controlled in cell-type-specific and stimulus-dependent manners. NF-kB is a transcription factor consisting of a dimer of the Rel family proteins such as p65 (RelA), p50, p52, c-Rel and RelB (Baldwin, 1996) . In unstimulated cells, NF-kB is sequestered in the cytoplasm bound to an inhibitory protein IkB that includes several isoforms such as IkB-a and IkB-b. External stimuli such as TNF-a induce activation of NF-kB by promoting IkB kinase-dependent phosphorylation of IkB. The phosphorylated IkB is then ubiquitinated and degraded by proteasome. After release from IkB, NF-kB translocates into the nucleus, binds to a regulatory element of the target gene and controls its transcription.
Ca 2 þ -mobilizing reagents such as Ca 2 þ -ionophore (A23187) and thapsigargin, and a protein kinase C (PKC) activator phorbol-myristate-acetate (PMA) are also shown to induce IL-8 expression in various cell types (Okamoto et al., 1994; Kuhns et al., 1998) . PKC is shown to increase intracellular Ca 2 þ by phosphorylating inositol triphosphate receptor and allowing efflux of Ca 2 þ from the endoplasmic reticulum (Cameron et al., 1995) . Although a variety of external stimuli such as epidermal growth factor (EGF), IL-1b, platelet-derived growth factor (PDGF), substance P, endothelin, nerve growth factor (NGF) and serotonin have been demonstrated to increase intracellular Ca 2 þ in glioma cells (Bando et al., 1995; Kugaya et al., 1995; De Bernardi et al., 1996; Pita et al., 1999; Saqr et al., 1999) , effect of Ca 2 þ mobilization on IL-8 expression in the cells has not been studied to date. On the other hand, IL-8 action is exerted through G protein-coupled membrane receptors, CXCR-1 and -2, whose expression is detected not only in leukocytes but also in various other cell types . Although the IL-8 synthesis by glioblastoma has been established, its receptor expression and its autocrine and paracrine actions remain to be addressed.
A rise in intracellular Ca 2 þ leads to activation of calcineurin, a serine/threonine-specific and Ca 2 þ -calmodulin-dependent protein phosphatase (Klee et al., 1998; Hemenway and Heitman, 1999) . Cyclosporin A (CsA) and FK506, powerful immunosuppressants widely used in autoimmune disorders and organ transplantation, are known as specific inhibitors for calcineurin (Rao et al., 1997) . Recently, it is reported that CsA induces apoptosis of rat C6 glioma cells, demonstrating the direct effect of CsA on glioma cell functions (Pyrzynska et al., 2002) .
Based on these findings, the present study was undertaken to evaluate the effects of Ca 2 þ mobilization on IL-8 expression in human glioblastoma U251MG cells by utilizing Ca 2 þ -ionophore (A23187) and PMA, and also effects of CsA on the expression. Furthermore, their effects on invasive potential and proliferation of the cells were investigated, since IL-8 possesses motogenic and mitogenic actions as described above.
Results
CsA attenuates A23187/PMA-dependent IL-8 expression
Effects of A23187/PMA, TNF-a, CsA and FK506 on IL-8 mRNA expression in U251MG cells were examined by Northern blot analysis. As shown in Figure 1a with CsA alone had no effect on IL-8 production, whereas A23187/PMA markedly increased IL-8 concentration in culture media. This increase was significantly suppressed by CsA. The IL-8 accumulations in culture media well reflected its mRNA levels.
Both AP-1 and NF-kB sites in IL-8 promoter are necessary for A23187/PMA-dependent IL-8 expression and its inhibition by CsA
To identify the promoter region responsible for A23187/ PMA-dependent induction of IL-8 expression and its inhibition by CsA, U251MG cells were transfected with luciferase reporter plasmids driven by a series of 5 0 -deletion fragments of human IL-8 promoter. As shown in Figure 3a , when the cells transfected with À1460, À651 or À133 plasmid were treated with A23187/PMA, the luciferase activity was markedly increased. This increase was significantly inhibited by CsA. In contrast, the A23187/PMA-dependent promoter activation was not observed in the cells transfected with À60 plasmid, demonstrating that the À133 to À60 promoter region is responsible for the regulation by A23187/PMA and CsA.
Since earlier studies demonstrated the important roles of the AP-1 site (À126 to À120) and the NF-kB site (À81 to À72) in transcriptional activation of human IL-8 promoter (Yasumoto et al., 1992) , À133 reporter plasmids with a mutated AP-1 or NF-kB site were constructed, and luciferase reporter assay was carried out. As shown in Figure 3b , disruption of either AP-1 or NF-kB site resulted in a marked attenuation of the A23187/PMA-dependent promoter activation, indicating that both sites are necessary for full promoter activation by A23187/PMA and for its inhibition by CsA.
CsA attenuates A23187/PMA-dependent NF-kB activation
To elucidate proteins interacting the AP-1 and NF-kB sites, nuclear extracts were prepared from U251MG cells cultured with A23187/PMA and/or CsA for 1 h, and EMSA was performed using hIL8-AP1 oligo and hIL8-kB oligo as probes. As shown in Figure 4a , when hIL8-AP1 oligo was used, a single protein/DNA complex was detected in the unstimulated cells (lane 1). Density of the complex was not affected by CsA (lane 2), by A23187/PMA (lane 3), nor by the combined treatment (lane 4). The complex was supershifted by anti-c-Fos antibody (lane 5). When anti-c-Jun antibody was used for supershift analysis, density of the complex was reduced, and a faint supershifted complex appeared (lane 6). The complex was displaced with 50-fold molar excess of cold canonical AP-1 oligo (lane 8). These results indicated that the protein/DNA complex includes c-Fos/c-Jun heterodimer AP-1. However, the In contrast, when hIL8-kB oligo was used as a probe (Figure 4b Constitutive DNA-binding activities of C/EBPb and no alteration in its activities by A23187/PMA nor by CsA were observed in EMSA using hIL8-C/EBP oligo (data not shown).
CsA suppresses A23187/PMA-dependent degradation of IkB-a
To explore the mechanism for CsA-dependent suppression of NF-kB activation, degradation of IkB-a was investigated by Western blot analysis ( Figure 5 ). In accordance with EMSA study, IkB-a was rapidly degraded in response to A23187/PMA. However, CsA markedly delayed the degradation by A23187/PMA. Actin contents were altered neither by A23187/PMA nor by CsA. IkB-b degradation was not observed in response to either A23187/PMA or CsA (data not shown).
CsA suppresses A23187/PMA-dependent invasive potential of U251MG cells IL-8 belongs to the CXC chemokine family, and its action is mediated by membrane receptors, CXCR-1 and -2. Expression of these receptors in U251MG cells was examined by RT-PCR (Figure 6a ). When RT products prepared from human aortic smooth muscle cells (SMCs) were used for PCR, a single band was amplified by CXCR-1 primers and by CXCR-2 primers. The sizes of the bands were the expected lengths: 363 bp for CXCR-1 and 385 bp for CXCR-2, demonstrating the expression of both receptors in SMCs. A high level of CXCR-1 expression was also detected in U251MG cells, whereas CXCR-2 expression appeared to be much lower than that of CXCR-1. No bands were amplified from the samples in which reverse transcriptase was omitted from reverse transcription reaction (data not shown), indicating that contamination of our RNA samples with genomic DNA was, if any, below the detectable level.
To address whether CXCR-1 and -2 expressed in U251MG cells are functional or not, we first assessed the invasive potential of U251MG cells utilizing Matrigel invasion chambers. The cells were seeded on Figure 4 CsA attenuates A23187/PMA-dependent NF-kB activation. Nuclear extracts prepared from U251MG cells cultured with A23187 (Ion)/PMA in the presence or absence of CsA for 1 h were subjected to EMSA using hIL8-AP1 oligo (panel a) and hIL8-kB oligo (panel b) as probes. Representative images by BAS 2000 system are shown. Supershift analysis was performed using antibodies directed against c-Fos, c-Jun (panel a), p65 and p50 (panel b). Competition assay was performed using canonical AP-1 oligo (panel a) and canonical kB oligo (panel b).The closed and open arrowheads represent specific protein/DNA complexes and supershifted complexes, respectively. The asterisks indicate nonspecific binding Figure 5 CsA attenuates A23187/PMA-dependent degradation of IkB-a. Cytosolic extracts prepared from U251MG cells cultured with A23187 (Ion)/PMA in the presence or absence of CsA for the indicated time were subjected to Western blot analysis using antiIkB-a or anti-actin antibodies the filter of the upper chamber in the presence or absence of IL-8, A23187/PMA and CsA. After 24-h incubation, the cells that migrated to the lower side of the filter by passing through the basement membrane matrix and 8-mm pores of the filter were counted (Figure 6b ). Even in unstimulated conditions, approximately 25% cells migrated to the lower side of the filter. CsA alone had no effect on the invasive potential. Treatment of the cells with 10 nM IL-8 resulted in a significant increase in the potential, which was, however, not inhibited by CsA. When the cells were treated with A23187/PMA, the number of migrated cells was markedly increased by threefold above the unstimulated conditions. This increase was significantly suppressed by CsA. A23187/PMA-dependent suppression of invasive potential was reverted by 10 nM IL-8. Representative microscopic photographs for the migrated cells are shown in Figure 6c .
CsA suppresses IL-8-dependent proliferation of U251MG cells
We next examined the effects of A23187/PMA and IL-8 on proliferation of U251MG cells by WST-1 assay. As shown in Figure 7 , treatment of the cells with 10 nM IL-8 significantly increased the number of cells. This increase was significantly attenuated by treatment with CsA. In contrast, CsA alone had no effect on the growth. Unexpectedly, A23187/PMA markedly decreased, rather than increased, the cell number at Day 4.
Discussion
The present study demonstrated that two different stimuli, A23187/PMA and TNF-a, increase IL-8 mRNA levels in human glioblastoma U251MG cells. A23187/ PMA-dependent increase is, at least in part, due to transcriptional activation of IL-8 gene, because A23187/ PMA was capable of increasing the activity of luciferase reporter gene driven by IL-8 promoter. Subsequent transfection analysis using 5 0 -deleted promoters revealed that the À133 to À60 region is responsible for the transcriptional activation. Mutation of either AP-1 or NF-kB site in this region resulted in a marked reduction in the promoter inducibility by A23187/PMA. However, EMSA study revealed that only NF-kB binding is inducible in response to A23187/PMA, whereas AP-1 is constitutively activated. These results thus suggest that AP-1 contributes to the basal promoter activity, and that NF-kB, cooperatively with AP-1, mediates A23187/ PMA-dependent IL-8 induction. Similar results were reported by Yasumoto et al. (1992) . They showed that mutation of either site for NF-kB or AP-1 abolished IL-8 promoter responsiveness to TNF-a and interferon-g in human gastric cancer cells.
Interestingly, although A23187/PMA and TNF-a both increased IL-8 expression, CsA and FK506 attenuated only A23187/PMA-dependent expression. This inhibitory effect can be attributed to the decrease in transcription of IL-8 gene, because luciferase reporter gene assay showed that CsA also attenuates A23187/ PMA-dependent activation of IL-8 promoter. Subsequent EMSA analysis demonstrated that the decrease in NF-kB binding to its cognate site in the promoter is responsible for the inhibitory action of CsA. Indeed, it was also demonstrated that CsA markedly delays the A23187/PMA-dependent IkB-a degradation.
CsA was reported to inhibit chymotrypsin-like activity of 20S proteasome in vitro and that it prevented lipopolysaccharide-induced IkB-a degradation in RAW 264.6 murine macrophage cell line (Meyer et al., 1997) . This is, however, not the case in our study, because CsA prevented only A23187/PMA-dependent NF-kB activation. If CsA inhibits proteasome activity in U251MG cells, both TNF-a-and A23187/PMA-dependent NF-kB activation should be prevented. It is thus speculated that CsA might affect a certain step upstream of IkB-a phosphorylation in A23187/PMA-elicited intracellular signaling pathway. As it is established that CsA and FK506 are specific inhibitors for calcineurin (Cn), it is likely that Cn mediates A23187/PMA-dependent IkB-a degradation and NF-kB activation in U251MG cells. Indeed, involvement of Cn in NF-kB activation was demonstrated in Jurkat T cells (Frantz et al., 1994) . Expression of the constitutively active form of Cn was shown to increase NF-kB binding by enhancing degradation of IkB-a. It was recently shown that Cn and PKC synergize to activate IkB kinase and NF-kB in human T lymphocytes (Trushin et al., 1999) . Our present result is compatible with these findings, and suggests that Cn/PKC-mediated degradation of IkB-a is not restricted to T cells. However, how Cn/PKC activates IkB kinase is still unknown. As IkB kinase was shown to be phosphorylated and activated by other kinases such as NF-kB-inducing kinase (NIK) and NFkB-activating kinase (NAK), it is unlikely that Cn directly activates IkB kinase. Since some isoforms of PKC were shown to activate IkB kinase (Vertegaal et al., 2000; Saijo et al., 2002) , Cn may function upstream of IkB kinase by potentiating the activity of such PKC or by modifying other effectors for IkB kinase. Although a precise pathway is unknown, the present study strongly suggests the presence of Ca 2 þ -Cn-NF-kB signaling pathway, leading to IL-8 expression in U251MG cells.
IL-8 has been shown to stimulate proliferation of a variety of cancer cells such as melanoma, pancreatic cancer and colon cancer cells (Schadendorf et al., 1993; Miyamoto et al., 1998; Brew et al., 2000) . However, the effect of IL-8 on glioma cell growth seems to be elusive. It was reported that IL-8 can increase growth of human glioma NP-1 cells, and this increase is inhibited by anti-IL-8 antiserum and retroviral expression of antisense IL-8 in the cells (Yamanaka et al., 1995) , suggesting that IL-8 may serve as an autocrine growth factor. It was, however, reported by using in situ hybridization that CXCR-1 and -2 expression is not detected in glioblastoma sections prepared from patients, but detected in infiltrating leukocytes (Desbaillets et al., 1997) . Recently, it was shown by RNase protection assay that five out of 16 glioma cell lines express substantial amounts of CXCR-1 and -2 mRNA . In this study, it was demonstrated by RT-PCR that both CXCR-1 and -2 are expressed in U251MG cells. These receptors may be functional, because IL-8 was capable of stimulating proliferation of the cell. Higher expression of CXCR-1 than -2 in U251MG cells is relevant to the recent report by Flynn et al. (2003) , demonstrating a high level of CXCR-1 expression in primary human astrocytes isolated from adult temporal lobe, with a low level of CXCR-2. The discrepancy for CXCR expression among glioma cell lines and glioblastoma sections might be due to their variable expression levels and/or culturing conditions.
The present study further demonstrated that CsA inhibits the IL-8-dependent growth of U251MG cells. Since CsA alone had no effect on growth of the control cells, CsA might exert a specific, inhibitory action on the IL-8-dependent intracellular signaling pathway, leading to cell proliferation. On the other hand, it was reported that CsA induces apoptosis of rat C6 glioma cells (Pyrzynska et al., 2002) . However, in our experiments, morphological changes of U251MG cells indicative of apoptosis were not detected by microscopic observation. This may be due to the difference in doses of CsA used. More than 40 mM CsA is required for inducing apoptosis of C6 glioma cells, which is much higher than the dose we used in this study (1 mM).
The finding that treatment of U251MG cells with A23187/PMA decreased, rather than increased, the cell number at day 4 was unexpected, because such treatment for 24 h results in more than 10 nM of IL-8 accumulation in culture media (Figure 2) , seemingly sufficient to stimulate the proliferation. However, it is well known that long-lasting treatment of cells with PMA causes downregulation or exhaustion of PKC (Couldwell et al., 1990) . Thus, the growth inhibition by extended treatment with A23187/PMA may indicate that the proliferation and viability of U251MG cells largely depend on PKC activity.
IL-8 has also been shown to stimulate migration of cancer cells such as melanoma, colon cancer and prostate cancer cells (Wang et al., 1990; Reiland et al., 1999; Wilson et al., 1999) , which may be relevant to tumor invasion and metastasis. However, its effect on glioblastoma cells has not been studied. In the present study, invasive potential of U251MG cells was assessed by using Matrigel invasion chambers. Treatment of the cells with IL-8 significantly increased the invasive potential, but this increase was not inhibited by CsA. In contrast, A23187/PMA-dependent increase was significantly suppressed by CsA. This CsA-dependent suppression was reversed by treatment with IL-8. These results strongly suggest that the newly synthesized IL-8 in response to A23187/PMA contributes, at least in part, to the increased invasive potential in an autocrine and paracrine fashion. Note that the IL-8-dependent migration was insensitive to CsA, but its proliferation was sensitive to CsA, indicating the presence of distinct intracellular signaling pathways leading to migration and to growth.
Recently, clinical application of CsA and FK506 to treatment of stroke and spinal cord injury has been expected, because these drugs have been proven to possess neuroprotective effects in many experimental models, although the underlying mechanism is unknown (Kelly and Sharkey, 2001) . In the present study, we demonstrate a novel aspect of biological effects of CsA on glioblastoma U251MG cells. Since it is demonstrated that CsA exerts multiple inhibitory actions on glioblastoma cell functions such as IL-8 production, invasive potential and proliferation, CsA can also be expected as a potential therapeutic adjuvant for glioma treatment.
Materials and methods

Cell culture
U251MG cells, a human cell line derived from glioblastoma, were obtained from the Memorial Sloan Kettering Cancer Center (NY, USA), and were cultured in minimum essential medium alpha medium (a-MEM) supplemented with 10% fetal bovine serum (FBS) and antibiotics (penicillin and streptomycin). The cells, cultured to subconfluence, were treated, alone or in combination, with 1 mM Ca 2 þ -ionophore (A23187, Wako Pure Chemical, Japan), 50 nM phorbol-12-myristate-13-acetate (PMA, Sigma, USA), 100 U/ml human recombinant TNF-a (Asahi Chemical, Japan), 1 mM CsA (Wako), 1 mM FK506 (Fujisawa Pharmaceutical, Japan) and 10 nM human recombinant IL-8 (Sigma).
Northern blot analysis
Total RNA was extracted by the acid guanidinium thiocyanate-phenol-chloroform method (Chomczynski and Sacchi, 1987) . Northern blot analysis was performed as described in our previous report (Kambe et al., 1988) . Briefly, 12 mg of total RNA was electrophoresed and blotted onto a nylon membrane, which was then hybridized with [ 32 P]dCTP-labeled human IL-8 and human glyceraldehyde-3-phosphate-dehydrogenase (GAPDH) cDNAs (Sato et al., 1996) . After wash, the membrane was subjected to quantitative analysis using BAS 2000 bioimage analyzer (Fuji Photo Film, Japan).
Electrophoretic mobility shift assay (EMSA)
Procedures for preparation of nuclear extracts and EMSA were described in our previous report (Nagaya and Jameson, 1993) . The nuclear extract (10 mg) was incubated with 32 Plabeled EMSA probe, and electrophoresed with polyacrylamide gel. The gel was dried and subjected to BAS 2000 analyzer. Nucleotide sequences for EMSA probes are as follows: hIL8-kB oligo, 5 0 -GATCGTGGAATTTCCTCTC-3 0 , contains an NF-kB-binding site (À81 to À72, underlined) in the promoter of human IL-8 gene (transcription start site is numbered as þ 1, DDBJ Accession Number M28130). hIL8-AP1 oligo, 5 0 -GTGTGATGACTCAGGTTTGC-3 0 , contains an AP-1-binding site (À126 to À120, underlined). hIL8-C/EBP oligo, 5 0 -GCCATCAGTTGCAAATCGTGGC-3 0 , contains a C/EBPb-binding site (À93 to À84, underlined). They were labeled with [ 32 P]dCTP by Klenow enzyme. To identify the binding proteins, supershift analysis was performed using antibodies directed against p50, p65, c-Rel, RelB, c-Fos, c-Jun and C/EBPb (Santa Cruz, USA). Competition assay was performed using 50-fold molar excess of cold oligonucleotide as follows. Canonical AP-1 oligo, 5 0 -TCGACTGTCTGACT CATGCTCTCGA-3 0 , contains an AP-1 site in human collagenase promoter (DDBJ Accession No. AF007878 (Sarkar et al., 2000) . Canonical kB oligo, 5 0 -TCGAGCAGAG GGGACTTTCCGAGAGTCGA-3 0 , contains a kB site in mouse Igk enhancer (Baeuerle and Henkel, 1994) .
Luciferase reporter gene assay
A DNA fragment of human IL-8 promoter spanning from À1460 to þ 40 bp (DDBJ: M28130) was amplified by PCR and subcloned into pGEM-T easy plasmid (Promega, USA). After sequence verification, the fragment was inserted upstream of a luciferase reporter gene in pGL3-basic (Promega). A series of 5 0 -deletion fragments of the promoter (À651 to þ 40, À133 to þ 40 and À60 to þ 40) were also amplified and inserted into pGL3-basic. The reporter plasmid driven by À133 to þ 40 promoter is named p-133. Site-directed mutagenesis of the AP-1 and kB sites in p-133 was performed by PCR, which converted the AP-1 site (TGACTCA) to AGATCTA, and the kB site (TGGAATTTCC) to TTAACTTTCC. Procedures for transfection and for luciferase and b-galactosidase (b-gal) assays were described in our previous report (Kikumori et al., 2001) . In brief, U251MG cells (6 Â 10 4 cells/well), plated in 12-well plates and cultured for 1 day, were transfected with 0.8 mg/ well of reporter plasmid and 0.06 mg/well of b-gal-expressing plasmid (pSV-b-gal, Promega) by using lipofectamine reagent (Gibco BRL). After 10-h incubation with the liposome-DNA solution, the cells were cultured in growth media for 12 h, and then treated with A23187, PMA and/or CsA for another 24 h. The cells were then harvested and the luciferase and b-gal activities in the cell lysates were determined. Promoter activity was expressed as luciferase activity normalized by b-gal activity.
Western blot analysis
Procedures for preparation of cytosolic extracts and Western blot analysis were described in our previous report (Kikumori et al., 1998) . In brief, cytosolic extracts (50 mg) were subjected to polyacrylamide gel electrophoresis and blotted onto a membrane (Hybond-C super, Amersham, USA). The membrane was incubated with anti-IkB-a or anti-IkB-b antibodies (Santa Cruz) or anti-actin antibody (Sigma) and then incubated with anti-rabbit-IgG goat IgG conjugated with alkaline phosphatase (Zeimed, USA). After wash, it was subjected to color development reaction using NBT/BCIP tablet (Boehringer Mannheim, Germany).
Measurement of IL-8 concentrations in culture media
U251MG cells, grown to near confluence in a 60-mm dish, were treated for 24 h with A23187, PMA and CsA, alone or in combination in 3-ml fresh media. IL-8 concentration in the media was measured by enzyme-linked immunosorbent assay (ELISA, human IL-8 AN'ALYZA immunoassay kit, Genzyme Techne, USA).
Reverse transcription-polymerase chain reaction (RT-PCR)
Expressions of CXCR-1 and -2 were examined in U251MG cells and in human aortic SMCs (Iseki et al., 2000b) by RT-PCR. The primers for CXCR-1 and -2 were designed according to Hayes et al. (1998) ; CXCR-1: 5 0 -GGGGCCACAC CAACCTTC-3 0 and 5 0 -AGTGCCTGCCTCAATGTCTCC-3 0 , CXCR-2: 5 0 -CCGGGCGTGGTGGTGAG-3 0 and 5 0 -TCTGC CTTTTGGGTCTTGTGAATA-3 0 .
Cell proliferation assay U251MG cells (3 Â 10 3 cells/well) were seeded in 96-well plates and cultured in a-MEM supplemented with 1% FBS. After overnight culture, the cells were exposed to A23187, PMA, IL-8 and CsA, alone or in combination, and cell proliferation was assessed by the water-soluble tetrazolium (WST)-1 method (Cell counting kit, Dojindo, Japan) as described in our previous report (Iseki et al., 2000a) .
Matrigel invasion assay
Invasive potential of U251MG cells was assessed by using a Matrigel invasion chamber (BD Biosciences, USA). One chamber includes a cell insert and its well. The bottom of the cell insert consists of a filter with multiple 8-mm pores, which is coated with a basement membrane matrix (Matrigel). Approximately 2 Â 10 4 cells in 500 ml of serum-free a-MEM containing 0.1% bovine serum albumin were seeded in the cell insert and cultured with IL-8, A23187/PMA and/or CsA. The well was filled with 500 ml of a-MEM supplemented with 10% FBS. After 24-h incubation, the noninvasive cells present on the upper surface of the filter were wiped out with a cotton swab. The invasive cells migrated onto the lower surface of the filter were fixed and stained with Diff-Quick (American Scientific Products, USA), and the number of the cells were counted.
Statistical analysis
Statistical analysis was carried out by one-way fractional ANOVA (analysis of variance), followed by Fisher's protected least significant difference (PLSD) analysis.
